Literature DB >> 9848589

Patellar tendon defect during the first year after anterior cruciate ligament reconstruction: appearance on serial magnetic resonance imaging.

J P Bernicker1, J L Haddad, D M Lintner, T C DiLiberti, J R Bocell.   

Abstract

The purpose of this study was to use magnetic resonance imaging to evaluate various parameters of the patellar tendon during the first year after harvest for anterior cruciate ligament (ACL) reconstruction. Twelve consecutive patients were serially imaged on a 1.5 Tesla GE magnet (GE Medical Systems, Milwaukee, WI) with a dedicated knee coil at 3 weeks, 3 months, 6 months, and 1 year after undergoing ACL reconstruction using a central one-third patellar tendon autograft. The tendon defect was not closed primarily, but the paratenon was approximated. The following measurements were performed: tendon width, defect width, cross-sectional area of the tendon, and tendon length. In addition, the patellar bone harvest site was evaluated for healing. The width of the tendon defect decreased by 62% over 12 months (P < .05). Only two patients showed complete closure of the defect. Tendon width was noted to decrease by 6.5% (P=.017). The ratio of defect width to overall tendon width (designated R) decreased by 58% (P < .05). Tendon length was noted to decrease during this by 8% (P=.037). The tendon cross-sectional area was noted to increase by 9% at 1 year, but this was not found to be statistically significant (P=.39). One year after ACL reconstruction using a central one-third patellar tendon, the tendon defect has begun to reconstitute itself but there is still a significant gap. This persistent defect must be taken into consideration when planning revision ACL surgery using reharvest of the central one third of the patellar tendon. The entire tendon also exhibits a reduction in width and length, while cross-sectional area increases slightly. Complete healing of the graft defect can not be assumed at 12 months post-ACL reconstruction.

Entities:  

Mesh:

Year:  1998        PMID: 9848589     DOI: 10.1016/s0749-8063(98)70014-3

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  7 in total

1.  Muscle atrophy contributes to quadriceps weakness after anterior cruciate ligament reconstruction.

Authors:  Abbey C Thomas; Edward M Wojtys; Catherine Brandon; Riann M Palmieri-Smith
Journal:  J Sci Med Sport       Date:  2015-01-13       Impact factor: 4.319

2.  Healing of donor site in bone-tendon-bone ACL reconstruction accelerated with plasma rich in growth factors: a randomized clinical trial.

Authors:  Roberto Seijas; Marta Rius; Oscar Ares; Montserrat García-Balletbó; Iván Serra; Ramón Cugat
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-27       Impact factor: 4.342

3.  Patellar tendon donor-site healing during six and twelve months after Anterior Cruciate Ligament Reconstruction.

Authors:  Hamed Yazdanshenas; Firooz Madadi; Firoozeh Madadi; Eleby Rudolph Washington; Kristofer Jones; Arya Nick Shamie
Journal:  J Orthop       Date:  2015-06-23

Review 4.  A literature review of autograft and allograft anterior cruciate ligament reconstruction.

Authors:  Jonathan Marrale; Matthew C Morrissey; Fares S Haddad
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-04-12       Impact factor: 4.114

5.  Patellar tendon length after anterior cruciate ligament reconstruction: a comparative magnetic resonance imaging study between patellar and hamstring tendon autografts.

Authors:  Michael E Hantes; Vasilios C Zachos; Konstantinos A Bargiotas; Georgios K Basdekis; Apostolos H Karantanas; Konstantinos N Malizos
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-01-16       Impact factor: 4.114

Review 6.  Anterior cruciate ligament reconstruction: principles of treatment.

Authors:  Nikolaos K Paschos; Stephen M Howell
Journal:  EFORT Open Rev       Date:  2017-03-13

7.  Measurement of normal patellar ligament and anterior cruciate ligament by MRI and data analysis.

Authors:  Hongpo Wang; Caihong Hua; Hongkai Cui; Yuxia Li; Haixia Qin; Dongming Han; Junyan Yue; Changhua Liang; Ruimin Yang
Journal:  Exp Ther Med       Date:  2013-01-17       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.